# A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease

> **NCT01504295** · PHASE2 · COMPLETED · sponsor: **Brown University** · enrollment: 38 (actual)

## Conditions studied

- Alcoholism,
- Alcoholic Liver Disease

## Interventions

- **DRUG:** Metadoxine

## Key facts

- **NCT ID:** NCT01504295
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2015-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504295, "A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01504295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*